JAGX JAGUAR HEALTH INC Investor Conferences 8-K Filing 2025 - Investor Meetings On April 28, 2025, Jaguar Health, Inc. announced an investor webcast scheduled for April 30, 2025, to discuss results of a trial for a new liquid formulation of crofelemer used for rare diseases, presented on April 26, 2025.Get access to all SEC 8-K filings of the JAGUAR HEALTH INC